Chemical Compound

Budesonide Imp. H (EP); 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,20-dione; (16alpha)-16,17-[Butylidenebis(oxy)]-21-hydroxy-pregna-1,4,9(11)-triene-3,20-dione; 9,11-Anhydrobudesonide; 16alpha,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione; Budesonide Impurity H

CAS Registry Number 313474-58-7
Budesonide Imp. H (EP); 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,20-dione; (16alpha)-16,17-[Butylidenebis(oxy)]-21-hydroxy-pregna-1,4,9(11)-triene-3,20-dione; 9,11-Anhydrobudesonide; 16alpha,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione; Budesonide Impurity H 结构式
Primary record

Budesonide Imp. H (EP); 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,20-dione; (16alpha)-16,17-[Butylidenebis(oxy)]-21-hydroxy-pregna-1,4,9(11)-triene-3,20-dione; 9,11-Anhydrobudesonide; 16alpha,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione; Budesonide Impurity H

库存
7,983 克
纯度
99.8 %
CAS
313474-58-7

化合物标识与属性

CAS
313474-58-7
PubChem CID
15391895
SMILES
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5(C4=CC[C@@]3([C@@]2(O1)C(=O)CO)C)C
Canonical SMILES
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)C4=CC[C@]3(C)[C@]2(C(=O)CO)O1

名称与同义词

  • 9,11-Anhydrobudesonide
  • HGK3X9TC3Y
  • UNII-HGK3X9TC3Y
  • Budesonide EP Impurity H
  • Budesonide impurity H [EP]
  • 313474-58-7
  • FA146159
  • BUDESONIDE IMPURITY H [EP IMPURITY]
  • 9,11-Anhydrobudesonide(Mixture of Diastereomers)
  • CS-0166433
  • Budesonide EP Impurity H (Mixture of Epimer)
  • 9,11-Anhydrobudesonide (Mixture of Diastereomers)
  • Budesonide EP Impurity H (Mixture of Diastereomers)
  • (1S,2S,4R,8S,9S,13S)-8-(2-Hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-11,14,17-trien-16-one
  • 16alpha,17-((1RS)-Butylidenebis(oxy))-21-hydroxypregna1,4,9(11)-triene-3,20-dione
  • 16alpha,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione
  • Pregna-1,4,9(11)-triene-3,20-dione, 16,17-(butylidenebis(oxy))-21-hydroxy-, (16alpha)-
  • (6aS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
  • (6aS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (Budesonide Impurity
  • 16.ALPHA.,17-((1RS)-BUTYLIDENEBIS(OXY))-21-HYDROXYPREGNA1,4,9(11)-TRIENE-3,20-DIONE
  • Budesonide Imp. H (EP); 16alpha,17-[(1RS)-Butylidene-bis(oxy)]-21-hydroxypregna-1,4-diene-3,20-dione; (16alpha)-16,17-[Butylidenebis(oxy)]-21-hydroxy-pregna-1,4,9(11)-triene-3,20-dione; 9,11-Anhydrobudesonide; 16alpha,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione; Budesonide Impurity H
  • PREGNA-1,4,9(11)-TRIENE-3,20-DIONE, 16,17-(BUTYLIDENEBIS(OXY))-21-HYDROXY-, (16.ALPHA.)-